R
539561
vs
B
BSE Sensex 30
Over the past 12 months, REMLIFE has underperformed BSE Sensex 30, delivering a return of -81% compared to the BSE Sensex 30's +0% growth.
Stocks Performance
539561 vs BSE Sensex 30
Performance Gap
539561 vs BSE Sensex 30
Performance By Year
539561 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Remedium Lifecare Ltd
Glance View
Remedium Lifecare Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-01-12. Remedium Lifecare Limited is an India-based pharmaceutical company. The firm is aligned across two business verticals: Products and Services. The Products business comprises trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. The company is engaged in the business of trading in advanced pharmaceutical intermediates, API's and other pharma products used, such as iso propyl alcohol, cyclohexane, di iso propyl amine, ethyl acetate, hydrazine hydrate, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride, sodium carbonate (soda ash), amino isophthalic acid, tellurium(IV) oxide, Grignard reagent, selenium metal powder and trimethyl sulfoxonium iodide (TMSI). The company is involved with the manufacture of various APIs, such as atorvastatin calcium (Amorphous) and citalopram hydrochloride.
